|
Published in Volume 98, Issue 7
J. Clin. Invest.
98(7):
1575-1584 (1996).
doi:10.1172/JCI118951.
Copyright © 1996, The American Society for Clinical Investigation
Research Article
Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.
H Shimano,
J D Horton,
R E Hammer,
I Shimomura,
M S Brown and
J L Goldstein
Department of Molecular Genetics, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas 75235, USA.
The NH2-terminal domain of sterol-regulatory element binding protein-1a (SREBP-1a) activates transcription of genes encoding enzymes of cholesterol and fatty acid biosynthesis in cultured cells. This domain is synthesized as part of a membrane-bound precursor that is attached to the nuclear envelope and endoplasmic reticulum. In sterol-depleted cells a two-step proteolytic process releases this NH2-terminal domain, which enters the nucleus and activates transcription. Proteolysis is suppressed by sterols, thereby suppressing transcription. In the current experiments we produce transgenic mice that overexpress a truncated version of human SREBP-1a that includes the NH2-terminal domain but lacks the membrane attachment site. This protein enters the nucleus without a requirement for proteolysis, and therefore it cannot be down-regulated. Expression was driven by the phosphoenolpyruvate carboxykinase (PEPCK) promoter, which gives high level expression in liver. When placed on a low carbohydrate/high protein diet to induce the PEPCK promoter, the transgenic mice developed progressive and massive enlargement of the liver, owing to the engorgement of hepatocytes with cholesterol and triglycerides. The mRNAs encoding 3-hydroxy-3-methylglutaryl CoA (HMG CoA) synthase, HMG CoA reductase, squalene synthase, acetyl-CoA carboxylase, fatty acid synthase, and stearoyl-CoA desaturase-1 were all elevated markedly, as was the LDL receptor mRNA. The rates of cholesterol and fatty acid synthesis in liver were elevated 5- and 25-fold, respectively. Remarkably, plasma lipid levels were not elevated. The amount of white adipose tissue decreased progressively as the liver enlarged. These studies indicate that the NH2-terminal domain of SREBP-1a can produce major effects on lipid synthesis and storage in the liver.
|
|
Articles that cite this article:
CCAAT/enhancing binding protein β deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis
Shaikh Mizanoor Rahman, Jill M. Schroeder-gloeckler, Rachel C. Janssen, Hua Jiang, Ishtiaq Qadri, Kenneth N. Maclean, Jacob E. Friedman
Hepatol 45(5):1108. doi:10.1002/hep.21614 [CrossRef] Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
Mitsuhiro Watanabe, Sander M. Houten, Li Wang, Antonio Moschetta, David J. Mangelsdorf, Richard A. Heyman, David D. Moore, Johan Auwerx
J Clin Invest 113(10):1408. doi:10.1172/JCI21025 [CrossRef] Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
Douglas Osei-hyiaman, Michael Depetrillo, Pál Pacher, Jie Liu, Svetlana Radaeva, Sándor Bátkai, Judith Harvey-white, Ken Mackie, László Offertáler, Lei Wang
J Clin Invest 115(5):1298. doi:10.1172/JCI23057 [CrossRef] Blasts from the past
Paul A. Insel, Stuart Kornfeld, Philip W. Majerus, Andrew R. Marks, Paul A. Marks, Arnold S. Relman, Bruce F. Scharschmidt, Thomas P. Stossel, Ajit P. Varki, Stephen J. Weiss
J Clin Invest 114(8):1017. doi:10.1172/JCI23321 [CrossRef] Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I
Geneviève Martin, Hélène Duez, Christophe Blanquart, Vincent Berezowski, Philippe Poulain, Jean-Charles Fruchart, Jamila Najib-fruchart, Corine Glineur, Bart Staels
J Clin Invest 107(11):1423. doi:10.1172/JCI10852 [CrossRef] SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Jay D. Horton, Joseph L. Goldstein, Michael S. Brown
J Clin Invest 109(9):1125. doi:10.1172/JCI15593 [CrossRef] Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver
Kazuaki Miyake, Wataru Ogawa, Michihiro Matsumoto, Takehiro Nakamura, Hiroshi Sakaue, Masato Kasuga
J Clin Invest 110(10):1483. doi:10.1172/JCI15880 [CrossRef] Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
Lily Chao, Bernice Marcus-samuels, Mark M. Mason, Jaideep Moitra, Charles Vinson, Elif Arioglu, Oksana Gavrilova, Marc L. Reitman
J Clin Invest 106(10):1221. doi:10.1172/JCI11245 [CrossRef] Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways
Geoff H. Werstuck, Steven R. Lentz, Sanjana Dayal, Gazi S. Hossain, Sudesh K. Sood, Yuan Y. Shi, Ji Zhou, Nobuyo Maeda, Skaidrite K. Krisans, M. Rene Malinow
J Clin Invest 107(10):1263. doi:10.1172/JCI11596 [CrossRef] Cholesterol and atherosc lerosis
Paulus A. Kroon
Intern Med J 27(4):492. doi:10.1111/j.1445-5994.1997.tb02224.x [CrossRef] From fatty streak to fatty liver: 33 years of joint publications in the JCI
Joseph L. Goldstein, Michael S. Brown
J Clin Invest 118(4):1220. doi:10.1172/JCI34973 [CrossRef] Molecular Mechanism of Age-Specific Hepatic Lipid Accumulation in PPARα (+/−):LDLR (+/−) Mice, an Obese Mouse Model
Eiko Sugiyama, Shin Yokoyama, Lingling Jiang, Yufeng Li, Naoki Tanaka, Toshifumi Aoyama
Lipid 43(4):301. doi:10.1007/s11745-008-3161-x [CrossRef] Superiority of Dietary Safflower Oil over Olive Oil in Lowering Serum Cholesterol and Increasing Hepatic mRNAs for the LDL Receptor and Cholesterol 7.ALPHA.-Hydroxylase in Exogenously Hypercholesterolemic(ExHC) Rats.
Masao Sato, Susumu Yoshida, Koji Nagao, Katsumi Imaizumi
Biosci Biotechnol Biochem 64(6):1111. doi:10.1271/bbb.64.1111 [CrossRef]
|
